Long-Term Surgical Outcome of Indirect Bypass Surgery in Young Children With Moyamoya Disease

Neurosurgery. 2023 Oct 1;93(4):901-909. doi: 10.1227/neu.0000000000002489. Epub 2023 Apr 4.

Abstract

Background: The prognosis of moyamoya disease (MMD) in young children (younger than 4 years) is worse than that of older adults. The effectiveness of surgery is still inconclusive.

Objective: To evaluate long-term outcomes after indirect bypass in young children with MMD.

Methods: A total of 1417 MMD children underwent indirect bypass from August 1988 to October 2020. This study included 135 patients who were younger than 4 years at the time of surgery. The clinical features and surgical outcomes of these patients were assessed. We analyzed the long-term outcome of 102 children who were followed up for more than 5 years (mean: 18.8 years, range: 5-27.3 years). Cross-sectional analysis was performed to evaluate overall outcomes based on the Lansky Play Performance Scale (LPS). The annual risk of symptomatic stroke after surgery was calculated with a person-year method, and the event-free survival rate was evaluated using the Kaplan-Meier method.

Results: The overall clinical outcome was favorable (LPS ≥ 80) in 88% of the patients. The overall postoperative adverse event rate was 15%, including 1 death. At the last follow-up, 86% of patients who had seizures at diagnosis were seizure-free. During the follow-up, there were 3 symptomatic infarctions on the operated hemisphere (postoperative 3, 3, and 10 months each). There was no hemorrhagic event. The annual infarction rate was 0.16% per person-year. The 20-year event-free survival rates for symptomatic infarction were 97%.

Conclusion: Indirect bypass could provide a satisfactory long-term outcome and prevent recurrent stroke in young children with MMD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cerebral Infarction
  • Cerebral Revascularization* / methods
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Humans
  • Lipopolysaccharides
  • Moyamoya Disease* / surgery
  • Retrospective Studies
  • Stroke*
  • Treatment Outcome

Substances

  • Lipopolysaccharides

Supplementary concepts

  • Moyamoya disease 1